SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D. C. 20549
FORM 8-K
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): APRIL 22, 2004
HALSEY DRUG CO., INC.
616 N. NORTH COURT, SUITE 120, PALATINE, ILLINOIS 60067
(847-705-7709)
Incorporated under Commission I.R.S. Employer
the laws of File Number Identification Number
State of New York 1-10113 11-0853640
ITEM 12. RESULTS OF OPERATIONS AND FINANCIAL CONDITION
On April 22, 2004, Halsey Drug Co., Inc. (the "Company") issued a press
release disclosing the financial results for its fourth quarter ended December
31, 2003 and the twelve months ended December 31, 2003. A copy of the Company's
press release is attached as Exhibit 99.1 hereto.
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.
(B) EXHIBITS
EXHIBIT
NUMBER DESCRIPTION
------ -----------
99.1 Press Release dated April 22, 2004 Announcing Results for
Fourth Quarter ended December 31, 2003
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
HALSEY DRUG CO., INC.
By: /s/ Peter A. Clemens
--------------------
Peter A. Clemens
Vice President & Chief
Financial Officer
Date: April 22, 2004
3
EXHIBIT INDEX
EXHIBIT
NUMBER DESCRIPTION
------ -----------
99.1 Press Release dated April 22, 2003 Announcing Results for Fourth
Quarter ended December 31, 2003.
4